siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin-Reference-Cited by-同舟云学术

siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin

Published:2018-09 Issue: Volume:12 Page:805-816
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Zheng Shuquan,Wang Xiaoxia,Weng Yu-Hua,Jin Xingyu,Ji Jia-Li,Guo Liangxia,Hu Bo,Liu Nan,Cheng Qiang,Zhang Jianqi,Bai Huicheng,Yang Tongren,Xia Xin-Hua,Zhang Hong-Yan,Gao Shan,Huang Yuanyu

Funder

Beijing Institute of Technology Research Fund Program for Young Scholars

Fundamental Research Funds for the Central Universities

Hunan Provincial Natural Science Foundation of China

Hu-Xiang Young Talent Program

National Drug Program of China

Jiangsu Provincial Natural Science Foundation of China

Suzhou Ribo Life Science Co. Ltd.

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference50 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies;Garrido-Laguna;Nat. Rev. Clin. Oncol.,2015

3. Pancreatic adenocarcinoma;Ryan;N. Engl. J. Med.,2014

4. Recent progress in pancreatic cancer;Wolfgang;CA Cancer J. Clin.,2013

5. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma;Current Gene Therapy;2025-04

2. Current advances in non-viral nanoparticle-based gene therapy for effective management of cancer;Journal of Drug Delivery Science and Technology;2024-10

3. A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer;PLOS ONE;2024-04-18

4. Lipid nanoparticles for siRNA delivery in cancer treatment;Journal of Controlled Release;2023-09

5. RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST;Cellular Oncology;2023-04-22